NSEShareholders meetingResults31 Jul 2026
BALAXI PHARMACEUTICALS LIMITED
Shareholders meeting
Balaxi Pharmaceuticals Limited has informed the Exchange regarding Notice of 83rd Annual General Meeting to be held on 24th August, 2026. The meeting will be held through Video Conferencing / Other Audio Visual Means (VC/OAVM) and will consider and adopt the Audited Standalone Financial Statements for the financial year ended March 31, 2026, and the reports of the Board of Directors and Auditors thereon. The meeting will also consider the re-appointment of Mrs. Minoshi Maheshwari as an Independent Director of the Company.
NSECopy of Newspaper Publication20 Jul 2026
BALAXI PHARMACEUTICALS LIMITED
Copy of Newspaper Publication
Balaxi Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication regarding the 83rd Annual General Meeting to be held on 24th August, 2026, through Video Conferencing/OAVM and e-voting.
NSEReply to Clarification- Financial resultsResults14 Jul 2026
BALAXI PHARMACEUTICALS LIMITED
Reply to Clarification- Financial results
Balaxi Pharmaceuticals Limited has clarified discrepancies in its financial results for the quarter ended March 31, 2026, correcting errors in employee benefit expense and other comprehensive income in the standalone and consolidated XBRL filings.
NSEUpdates9 Jul 2026
BALAXI PHARMACEUTICALS LIMITED
Updates
Balaxi Pharmaceuticals has informed the Exchange regarding the re-lodgement of transfer requests of physical shares for the period ended June 2026, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
BALAXI PHARMACEUTICALS LIMITED
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Balaxi Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with dematerialization of securities for the quarter ended 30th June, 2026.
NSETrading Window26 Jun 2026
BALAXI PHARMACEUTICALS LIMITED
Trading Window
Balaxi Pharmaceuticals Limited has informed the Exchange regarding the closure of the trading window for insiders due to the upcoming declaration of unaudited financial results for the quarter ending 30th June, 2026.
NSEClarification - Financial ResultsResults24 Jun 2026
BALAXI PHARMACEUTICALS LIMITED
Clarification - Financial Results
The NSE has sought clarification from Balaxi Pharmaceuticals regarding its financial results for the quarter ended 31-Mar-2026 under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.